The Patent Finder

Dor Biopharma, Inc.

Also on record
Records under this name other than patents Dor Biopharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Dor Biopharma, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,535,650Stabilized reverse micelle compositions and uses thereof
Formerly held
Term ended
Term ended Sep 18, 2025 · USPTO record
Term endedTerm ended Sep 18, 2025USPTO record
US 8,263,582Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
Formerly held
Term ended
Term ended Mar 15, 2022 · USPTO record
Term endedTerm ended Mar 15, 2022USPTO record
US 7,323,471Topical azathioprine for the treatment of oral autoimmune diseases
Formerly held
Lapsed on the fee record
Ended Jan 29, 2012 · USPTO record
Lapsed on the fee recordEnded Jan 29, 2012USPTO record
US 6,187,335Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom
Lapsed on the fee record
Ended Feb 13, 2009 · USPTO record
Lapsed on the fee recordEnded Feb 13, 2009USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited